Morgan Stanley
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Morgan Stanley (MS) Business News
Track Morgan Stanley in real time with a live news feed covering Morgan Stanley stock news, official press releases, company announcements, and an archive of historical Morgan Stanley news. ...more
- Learn more about Morgan Stanley’s Revenue, CEO Salary, Employees, Revenue by Segment and Ownership.
- Check out competitors to Morgan Stanley in a side-by-side comparison.
- Explore additional financials, or market metrics (e.g., Market cap, PE ratio, Dividend).
- Access Company Filings & Reports for the latest updates.
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Loading news...
Banks show trading strength, caution on economic risk
BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)
JPM or MS: Which Stock Looks More Compelling Ahead of Q1 Earnings?
Stock Market Today (LIVE): Futures Rebound as Investors Shift Focus to Bank Earnings Despite U.S. Navy Blockade and Rising Crude
Breakfast News: Big Banks Launch Earnings Season
Week ahead: Goldman Sachs kicks off earnings as Iran, oil tensions linger
Morgan Stanley $MS Shares Acquired by Carnegie Investment Counsel
Wall Street Week Ahead
These 3 stocks reporting next week have a history of gaining after earnings
Robust Trading, IB Fee Growth to Support Morgan Stanley's Q1 Earnings
Loading more...
Wall Street banks reported booming trading revenues after a volatile first quarter but sounded caution about the ripple impact of higher oil and geopolitical risk on clients.
Read full articleNo data available for this time period.
Change the time range to see results.
Banks show trading strength, caution on economic risk
ReutersWall Street banks reported booming trading revenues after a volatile first quarter but sounded caution about the ripple impact of higher oil and geopolitical risk on clients.
Read full article
BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)
AccesswireVANCOUVER, BC / ACCESS Newswire / April 14, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce the successful completion of Good Manufacturing Practice (GMP) manufacturing of its clinical-grade sublingual Cladribine oral thin film (ODF) at its GMP manufacturing partner (CDMO) based in Munich, Germany. The completed GMP production campaign represents a significant operational milestone for BioNxt's lead development program, BNT23001, a proprietary sublingual Cladribine formulation designed for the treatment of relapsing forms of multiple sclerosis (MS) and other autoimmune neurodegenerative diseases.
Read full article
JPM or MS: Which Stock Looks More Compelling Ahead of Q1 Earnings?
Zacks Investment ResearchThe first-quarter earnings season for the banking sector begins this week, putting the spotlight on industry heavyweights like JPMorgan JPM and Morgan Stanley MS. As investors assess the investment opportunity, differences in business mix, earnings momentum and valuation may prove crucial in determining which bank is better positioned to outperform in the near term.
Read full article
Stock Market Today (LIVE): Futures Rebound as Investors Shift Focus to Bank Earnings Despite U.S. Navy Blockade and Rising Crude
Fool - Investing NewsTop insights from the latest market news from Monday, April 13, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Read full article
Breakfast News: Big Banks Launch Earnings Season
Fool - Investing NewsNew earnings season kicks off, chip shortages hitting AI, and more
Read full article
Week ahead: Goldman Sachs kicks off earnings as Iran, oil tensions linger
Proactive Investors - FinanceWall Street is heading into one of its busiest weeks of the quarter, with earnings season kicking off, fresh inflation data on deck, and a steady drumbeat...
Read full article
Morgan Stanley $MS Shares Acquired by Carnegie Investment Counsel
Defense WorldCarnegie Investment Counsel boosted its holdings in Morgan Stanley (NYSE: MS) by 216.3% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,794 shares of the financial services provider's stock after purchasing an additional 3,962 shares during the quarter. Carnegie Investment Counsel's holdings
Read full article
Wall Street Week Ahead
Seeking AlphaListen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Read full article
These 3 stocks reporting next week have a history of gaining after earnings
InvezzAs the first-quarter (Q1) earnings season shifts into high gear next week, investors are bracing for a wave of data from nearly 6% of the benchmark S&P 500 index. While heavy hitters like Netflix Inc and JPMorgan dominate the headlines, seasoned traders are looking at a specific subset of companies: those with a “beat and raise” pedigree.
Read full article
Robust Trading, IB Fee Growth to Support Morgan Stanley's Q1 Earnings
Zacks Investment ResearchMS to report Q1 earnings on April 15. Wall Street expects $19.62B revenues, EPS $3.08, with advisory fees +52% on trading and IB strength.
Read full article
No data available for this time period.
Change the time range to see results.





